Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein ...

Researchers are putting single-cell proteomics to work in fields like developmental biology, cell biology, cancer biology, and neuroscience. But proteins are a tougher challenge than nucleic acids.

We spoke with Dr. Niranjan Bose, managing director, Health & Life Sciences Strategy, Gates Ventures, about how proteomics-based biomarkers and international partnerships are changing the future of ...

Global Proteomics Market is estimated to be valued at USD 123.1 Billion by 2035, with an exponential growth of 12.55% in the ...

Large-scale proteomics equipment paves the way for the possibility of analyzing patient proteins to guide treatment, as is already the case with genetic information. At the National Cancer ...

Study designs in proteomics aim for inclusivity—to characterize every protein in a sample. However, extracting proteins from complex biological samples involves the use of harsh buffers ...

Proteomics is the predictive partner to genomics, and proteomics builds on the promise of genomics. There are notable differences between the two -omics, especially regarding the value they can ...

Observing proteins with precision in living cells has been a challenge for researchers across various disciplines. Now, Stefan Kubicek, PhD, and his team at CEMM Research Center for Molecular ...

Ignite Proteomics LLC announced the publication of a pivotal study in the British Journal of Cancer, which emphasizes the importance of measuring activated proteins in the AKT–mTOR signaling ...